Iimori Nozomi, Nishimura Shigehiko, Kushitani Yukako, Tokumoto Mao, Taenaka Naoyuki, Terashima Ken
Dept. of Surgery, Sumitomo Hospital.
Gan To Kagaku Ryoho. 2020 Dec;47(13):1983-1985.
Patients with cancerous ascites often manifest with various symptoms, such as abdominal distension and poor appetite. Ascites puncture may offer temporary relief, but there is a consentration loss of important proteins, such as albumin and immunoglobulin. Cell-free and concentrated ascites reinfusion therapy(CART)is helpful to compensate for this loss of proteins. However, the volume of ascites that can be retrieved is small, and patients occasionally have high fever at the time of reinjection. CART modified by Keisuke Matsusaki(KM-CART)is an improved version of CART with respect to these points. We performed KM-CART for a woman with breast cancer with ascites arising from peritoneal dissemination, and she had a good QOL until she died. We hope that more patients will benefit from KM-CART.
癌性腹水患者常表现出各种症状，如腹胀和食欲不佳。腹水穿刺可能会提供暂时缓解，但会导致重要蛋白质如白蛋白和免疫球蛋白的浓度损失。无细胞浓缩腹水回输疗法（CART）有助于弥补这种蛋白质损失。然而，可回输的腹水量较少，且患者在回注时偶尔会出现高热。松崎启介改良的CART（KM-CART）在这些方面是CART的改进版本。我们对一名因腹膜播散导致腹水的乳腺癌女性患者进行了KM-CART治疗，她在去世前生活质量良好。我们希望更多患者能从KM-CART中受益。
